Table 3.
Total cholesterol (TC) contents in blood samples.
| Group | 0D | 6D | 12D | 18D | 24D | 30D | 36D | 42D |
|---|---|---|---|---|---|---|---|---|
| A | 79.06 ± 11.88 | 84.70 ± 20.02 | 66.45 ± 9.115 | 91.77 ± 11.27 | 122.9 ± 31.84 | 73.16 ± 12.32 | 61.99 ± 10.06 | 61.48 ± 10.08 |
| B | 84.12 ± 8.411 | 176.4 ± 36.61*** | 165.4 ± 27.44** | 262.6 ± 45.02*** | 359.9 ± 61.90*** | 296.0 ± 80.12*** | 290.8 ± 66.87*** | 290.1 ± 46.93*** |
| C | 83.40 ± 18.30 | 159.2 ± 26.99*** | 184.6 ± 84.74*** | 261.7 ± 41.11*** | 360.2 ± 84.24*** | 294.5 ± 111.8*** | 328.8 ± 126.5*** | 239.7 ± 69.45*** |
| D | 85.43 ± 18.49 | 161.2 ± 56.09*** | 194.6 ± 26.80∗∗∗, # | 257.0 ± 32.58*** | 247.3 ± 54.32∗∗∗, ### | 244.8 ± 41.50*** | 192.8 ± 33.40∗∗∗, ## | 227.3 ± 39.93∗∗∗, # |
| E | 80.97 ± 8.531 | 178.7 ± 42.40*** | 187.5 ± 55.53*** | 255.1 ± 27.57*** | 247.8 ± 74.33∗∗∗, ## | 221.8 ± 54.88∗∗∗, # | 198.2 ± 45.39∗∗∗, ## | 227.6 ± 28.22∗∗∗, ## |
| F | 89.7 ± 10.92* | 143.4 ± 30.45∗∗∗, # | 168.0 ± 28.74*** | 291.8 ± 72.83*** | 232.1 ± 95.54∗∗, ##,†† | 209.0 ± 57.89∗∗∗, # | 182.8 ± 47.29∗∗∗, ##,†† | 212.3 ± 43.93∗∗∗, ## |
| G | 88.61 ± 20.01 | 140.3 ± 26.14∗∗∗, # | 209.8 ± 54.84∗∗∗, # | 293.4 ± 47.51∗∗∗,† | 227.2 ± 57.10∗∗∗, ### | 216.3 ± 47.35∗∗∗, # | 186.9 ± 104.9∗∗∗, # | 188.0 ± 50.93∗∗∗, ### |
| H | 90.65 ± 26.83 | 244.4 ± 87.23∗∗∗, #,† | 211.1 ± 33.37∗∗∗, ## | 296.5 ± 73.34*** | 237.5 ± 44.76∗∗∗, ### | 219.9 ± 58.06∗∗∗, # | 262.6 ± 60.32∗∗∗,† | 299.4 ± 70.86∗∗∗,† |
| I | 82.85 ± 7.949 | 183.6 ± 55.04*** | 227.7 ± 42.07∗∗∗, ### | 274.7 ± 60.25*** | 235.5 ± 63.81∗∗∗, ### | 238.4 ± 82.48*** | 239.5 ± 43.00*** | 263.3 ± 53.51*** |
| J | 78.25 ± 10.91 | 134.6 ± 17.74∗∗∗, ## | 160.9 ± 22.66*** | 237.9 ± 32.93*** | 243.7 ± 40.02∗∗∗, ### | 259.5 ± 61.93*** | 237.4 ± 91.13*** | 250.9 ± 34.42*** |
Total cholesterol (TC) contents were assayed by assay kits as described in the text.
Values were mean ± SD (n = 12) and expressed in mg/dL.
The * indicates a significant difference compared with control group, *P < 0.05, **P < 0.01, ***P < 0.001.
The # indicates a significant difference compared with model group, # P < 0.05, ## P < 0.01, ### P < 0.001.
The † indicates a significant difference compared with PMR group (same dosage level, F compared with C, G compared to D, H compared to E), † P < 0.05, †† P < 0.01.